The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review.

Authors:
Ren M; Liu Y; Ni X; Kuang Z; Luo X and 4 more

Journal:
Integr Med Res

Publication Year: 2022

DOI:
10.1016/j.imr.2022.100886

PMCID:
PMC9359601

PMID:
35967901

Journal Information

Full Title: Integr Med Res

Abbreviation: Integr Med Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interests Y Chen is an editorial board member of the journal but his editorial board membership status had no bearing on the editorial process or decision. The authors declare no other conflict of interests."

Evidence found in paper:

"Funding This study was supported by the Guangdong Provincial Key Laboratory of Research on Emergency in Traditional Chinese Medicine (No. 2017B030314176), and the National Key Research & Development Program of China Research on the Development and Evaluation of International Standards of Traditional Chinese Medicine (No. 2019YFC1712003)."

Evidence found in paper:

"We conducted a scoping review to identify the role of acupuncture in the treatment, prevention and rehabilitation of patients with COVID-19. We performed this scoping review following the methodology recommended by Joanna Briggs Institute (JBI) and followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) statement to draft this paper (Supplement 1). This scoping review has been registered in the Open Science Framework Registries (Registration DOI: 10.17605/OSF.IO/Z35WN). Study registration: Open Science Framework Registries (Registration DOI: 10.17605/OSF.IO/Z35WN; https://osf.io/z35wn)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025